Metabolic Syndrome and Insulin Resistance in Schizophrenia Patients Receiving Antipsychotics Genotyped for the Methylenetetrahydrofolate Reductase (MTHFR) 677C/T and 1298A/C Variants

INTRODUCTION: The metabolic syndrome and insulin resistance represent growing concerns related to atypical antipsychotic (AAP) use as their incidence in the schizophrenia population is two to four fold higher than the general population. Reduced methylenetetrahydrofolate reductase (MTHFR) activity,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ellingrod, Vicki L., Miller, Del D., Taylor, Stephan F., Moline, Jessica, Holman, Timothy, Kerr, Jane
Format: Artigo
Idioma:Inglês
Publicat: 2007
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2271139/
https://ncbi.nlm.nih.gov/pubmed/17976958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2007.09.030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars